The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Effective control of plasmid DNA is paramount since plasmids are critical starting materials for the generation of viral vectors and mRNA used in many cell and gene therapies. In their latest publication, a collaboration of industry colleagues at BioPhorum discuss current best practices and emerging technologies aimed at complementing broader industry efforts to advance release testing of plasmid DNA and the bacterial master cell banks used to produce them.
Speaker(s):
Lili
Belcastro,
Senior Principal Scientist,
Bristol Myers Squibb
You must be logged in and own this session in order to
post comments.